Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
The powerful combination of Aprecomm's CPE management and customer experience software, with VECTOR's expertise in network ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback